Primary Site >> Biliary tract Cancer

Gene >> ZEB2

Journal: PLoS One. 2016 Jan 4;11(1):e0145985.
Title: A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.
Author: Sakamoto, Takuya|Kobayashi, Shogo|Yamada, Daisaku|Nagano, Hiroaki|Tomokuni, Akira|Tomimaru, Yoshito|Noda, Takehiro|Gotoh, Kunihito|Asaoka, Tadafumi|Wada, Hiroshi|Kawamoto, Koichi|Marubashi, Shigeru|Eguchi, Hidetoshi|Doki, Yuichiro|Mori, Masaki
PMID: 26726879
Journal: Oncotarget. 2017 May 23;8(21):34698-34708.
Title: MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.
Author: Zu, Chao|Liu, Shizhang|Cao, Wei|Liu, Zongzhi|Qiang, Hui|Li, Yong|Cheng, Chong|Ji, Le|Li, Jianhui|Li, Jingyuan
PMID: 28423728
Journal: Int J Oncol. 2017 Sep;51(3):771-780.
Title: Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.
Author: Miwa, Takeshi|Nagata, Takuya|Kojima, Hirofumi|Sekine, Shinichi|Okumura, Tomoyuki
PMID: 28677740
Journal: Oncotarget. 2018 Apr 13;9(28):20034-20047.
Title: Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma.
Author: Ueno, Takashi|Tsuchikawa, Takahiro|Hatanaka, Kanako C|Hatanaka, Yutaka|Mitsuhashi, Tomoko|Nakanishi, Yoshitsugu|Noji, Takehiro|Nakamura, Toru|Okamura, Keisuke|Matsuno, Yoshihiro|Hirano, Satoshi
PMID: 29732001